STATINS MORE THAN CHOLESTEROL LOWERING AGENTS IN ALZHEIMER DISEASE: THEIR PLEIOTROPIC FUNCTIONS AS POTENTIAL THERAPEUTIC TARGETS

Similar Articles Added Earlier

• Aluminum-Induced Entropy in Biological Systems: Implications for Neurological Disease

  Over the last 200 years, mining, smelting, and refining of aluminum (Al) in various forms have increasingly exposed living species to this naturally abundant metal. Because of its prevalence in the earth’s crust, prior to its recent uses it was regarded as inert and therefore harmless...

• Prediction of LDL cholesterol response to statin using transcriptomic and genetic variation | Genome Biology | Full Text

  Statins are widely prescribed for lowering LDL-cholesterol (LDLC) levels and risk of cardiovascular disease. There is, however, substantial inter-individual variation in the magnitude of statin-induced LDLC reduction. To date, analysis of individual DNA sequence variants has explained only a small...

• Recovering from anorexia on a health-obsessed campus – Massachusetts Daily Collegian

  Kate Leddy discusses the difficulties of recovering from an eating disorder at a university known for its promotions of healthy living and fitness.

• Do BAT receptors hold the key to treating obesity and diabetes? New research suggests that transient receptor channels (TRPs) activated in progenitor cells can help create more -- ScienceDaily

  Scientists have discovered a way to increase the amount of metabolism-boosting brown adipose tissue (BAT) ('good' fat) by employing two receptors on BAT cells as potential therapeutic targets.

• Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins | Nature Communications

  Statins effectively lower LDL cholesterol levels in large studies and the observed interindividual response variability may be partially explained by genetic variation. Here we perform a pharmacogenetic meta-analysis of genome-wide association studies (GWAS) in studies addressing the LDL...